Old Web
English
Sign In
Acemap
>
Paper
>
The FLT3 F691L Gatekeeper Mutation Promotes Clinical Resistance to Gilteritinib + Venetoclax (GILT + VEN) in AML
The FLT3 F691L Gatekeeper Mutation Promotes Clinical Resistance to Gilteritinib + Venetoclax (GILT + VEN) in AML
2021
Setareh Sharzehi
Sunil K. Joshi
Janet Pittsenbarger
Jeffrey W. Tyner
Elie Traer
Keywords:
Gilteritinib
Cancer research
Biology
Mutation (genetic algorithm)
Ven
Venetoclax
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]